ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE927.90-37.3 (-3.86 %)
PREV CLOSE ( ) 965.20
OPEN PRICE ( ) 942.05
BID PRICE (QTY) 927.45 (7)
OFFER PRICE (QTY) 930.25 (2)
VOLUME 3938
TODAY'S LOW / HIGH ( )925.00 956.55
52 WK LOW / HIGH ( )516.6 1093.05
NSE930.25-35.35 (-3.66 %)
PREV CLOSE( ) 965.60
OPEN PRICE ( ) 960.00
BID PRICE (QTY) 929.40 (4)
OFFER PRICE (QTY) 930.40 (4)
VOLUME 154922
TODAY'S LOW / HIGH( ) 926.70 960.00
52 WK LOW / HIGH ( )517.05 1094
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.